Sort   by:  
 Page size 
UnknownFibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.
Not available
S-EPMC7982779 | biostudies-literature
UnknownUntangling Sex Dimorphisms in Coagulation: Initial Steps Toward Precision Medicine for Trauma Resuscitation.
Not available
S-EPMC8610776 | biostudies-literature
UnknownExamining the Effect of Hypertonic Saline Administered for Reduction of Intracranial Hypertension on Coagulation.
Not available
S-EPMC7050279 | biostudies-literature
UnknownDense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
Not available
S-EPMC7546039 | biostudies-literature
UnknownOmics Signatures of Tissue Injury and Hemorrhagic Shock in Swine.
Not available
S-EPMC10728352 | biostudies-literature
UnknownBioengineered human blood vessels to treat hospital-acquired vascular complications.
Not available
S-EPMC12547166 | biostudies-literature
UnknownActin is associated with tissue injury in trauma patients and produces a hypercoagulable profile in vitro.
Not available
S-EPMC8610777 | biostudies-literature
UnknownUnlocking the potential of TIPS placement as a bridge to elective and emergency surgery in cirrhotic patients: a meta-analysis and future directions for endovascular resuscitation in acute care surgery.
Not available
S-EPMC10111768 | biostudies-literature
UnknownIs there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Not available
S-EPMC7147395 | biostudies-literature
UnknownTrauma patients with type O blood exhibit unique multiomics signature with decreased lectin pathway of complement levels.
Not available
S-EPMC11502284 | biostudies-literature
Sort   by:  
 Page size